On February 11, Zhuo Fumin, Executive Chairman of the Chamber of Commerce, Chairman of Yuanxing Capital, and Management Partner, visited and inspected the Shanghai Keensea Enterprise Development Group. Chen Guobao, the chairman of the Chamber of Commerce and Chairman of Shanghai Keensa Enterprise Development Group, warmly received and discussed. Zhuo Xingyu, vice chairman of the Youth Federation of the Chamber of Commerce and the chairman of the Yuanxing Yuhan Fund, and the heads of related enterprises attended the inspection activities.

Zhuo Fumin and his party visited the two company exhibition halls, R & D laboratories and production lines of Keensea Medical and Keensea New Materials of the Keensea Group. The heads of the two companies introduced the development process, business conditions and future planning of the enterprise.

At the symposium, the two sides discussed in depth on further exchanges and cooperation in follow -up.

Zhuo Fumin asked the product research and development and market situation in detail, praised the company's research and development and market progress, and put forward many valuable suggestions in technological innovation and market expansion. Chen Guobao said that the Keensea Group followed the nationalization of high -end medical device and high -end nano -new material technology innovation direction advocated by the country, and launched high -tech new products with leading technology and market competitiveness. Continue to maintain leading and rising momentum.

Keensea Medical Technology Co., Ltd.
Keensea Medical Technology Co., Ltd. was established in January 2021 and was invested by the Hong Kong Main Board listed company Keensea International (HK02225), with a registered capital of 30 million yuan. The company is located in the Shanghai Jiading Industrial Zone. The company focuses on the overall solution of minimally invasive medical devices such as high -end medical endoscopes, and builds a closed -loop industry chain for research and development, production, sales and services. The company's products cover the 4K ultra -high -definition endoscopic system, 3D and naked eye 3D image processing system, 4K fluorescence and future multi -spectrum ultra -high -definition endoscopy system, 8K endoscope system and integrated operating room system solution. 4K and 3D high -definition endoscopes developed by the company are about to pass the approval of the Shanghai Pharmaceutical Supervision Bureau and are produced in batches. Its technological leading 4K fluorescent endoscope products are also planned to promote the market this year.

Shanghai Keensea New Material Technology Co., Ltd.
Shanghai Keensea New Materials Technology Co., Ltd. was established in 2018 and is located in the Jiading Industrial Zone of Shanghai with a registered capital of 50 million yuan. At this stage, the company is mainly engaged in the research and development and production of graphene raw materials and functional application products. The company has a number of doctoral R & D teams. It has successfully developed a variety of graphene application products such as graphene heat condition, graphene antiviral materials, and has made significant breakthroughs in multiple frontier applications.